According to Cognitive Market Research, the global diabetic macular edema market size is USD 3951.2 million in 2024 and will expand at a compound annual growth rate (CAGR) of 1.60% from 2024 to 2031.
North America held the major market, accounting for more than 40% of global revenue. With a market size of USD 1580.48 million in 2024, it will grow at a compound annual growth rate (CAGR) of -0.2% from 2024 to 2031.
Europe accounted for a share of over 30% of the global market size of USD 1185.36 million.
Asia Pacific held the market of around 23% of the global revenue with a market size of USD 908.78 million in 2024 and will grow at a compound annual growth rate (CAGR) of 3.6% from 2024 to 2031.
Latin America's market has more than 5% of the global revenue, with a market size of USD 197.56 million in 2024, and will grow at a compound annual growth rate (CAGR) of 1.0% from 2024 to 2031.
The Middle East and Africa held the major markets, accounting for around 2% of the global revenue. The market was USD 79.02 million in 2024 and will grow at a compound annual growth rate (CAGR) of 1.3% from 2024 to 2031.
The intravitreal injections held the highest diabetic macular edema market revenue share in 2024.
